(Q44066657)

29 November 2017

title

HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy (English)

1 reference

29 November 2017

1 reference

T-W Wu

1

1 reference

29 November 2017

C-C Chu

2

1 reference

29 November 2017

H-W Chang Liao

3

1 reference

29 November 2017

S-K Lin

4

1 reference

29 November 2017

T-Y Ho

5

1 reference

29 November 2017

M Lin

6

1 reference

29 November 2017

H H Lin

7

1 reference

29 November 2017

L-Y Wang

8

1 reference

29 November 2017

publication date

28 November 2013

1 reference

29 November 2017

1 reference

29 November 2017

volume

15

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

47-53

1 reference

https://scigraph.springernature.com/pub.10.1038/gene.2013.62

29 November 2017

exact match

0 references

cites work

Epidemiology of viral hepatitis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Hepatitis B: the virus and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Hepatitis B virus infection--natural history and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Determination of immune memory to hepatitis B vaccination through early booster response in college students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Chronic hepatitis B infection in adolescents who received primary infantile vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Response to hepatitis B vaccine: multiple HLA genes are involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Association of HLA-DR14—DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

A biological role for the major histocompatibility antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Heterozygote advantage for HLA class-II type in hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

HBV-Specific Adaptive Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

To kill or to cure: options in host defense against viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Immunology of hepatitis B virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Contributions of humoral and cellular immunity to vaccine-induced protection in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

A gender gap in autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

17-beta-estradiol suppresses IL-2 and IL-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Estrogen alters thresholds for B cell apoptosis and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Estrogen enhances immunoglobulin production by human PBMCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

A yin-yang effect between sex chromosome complement and sex hormones on the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

A role for sex chromosome complement in the female bias in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Duration of humoral immunity to common viral and vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

The long-term survival of plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Plasma cells for a lifetime?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Contribution of stromal cells to the migration, function and retention of plasma cells in human spleen: potential roles of CXCL12, IL-6 and CD54.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.62

Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors

21 January 2018

1 reference

12 December 2020

Correlation analysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG

1 reference

12 December 2020

HLA-associated non-responsiveness to hepatitis B vaccine

1 reference

12 December 2020

Ambiguous DPB1 allele combinations resolved by direct sequencing of selectively amplified alleles

1 reference

12 December 2020

Cytotoxic T cells and viral hepatitis

1 reference

12 December 2020

Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women

1 reference

12 December 2020

Identifiers

DOI

10.1038/GENE.2013.62

1 reference

Dimensions Publication ID

29 November 2017

1001608924

0 references

1 reference